Showing results (421-430 of 470) with videos related to
Sort By:
Pageof 47
Frontiers in Immunology|September 6, 2023
A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcomeJohn Marsiglio, Jordan P McPherson, Magdalena Kovacsovics-Bankowski, et al.Cancer Genetics and Cytogenetics|June 15, 2004
Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogeneticsValérie Beyer, Chantal Castagné, Dominique Mühlematter, et al.Blood|April 2, 2014
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AMLJeffrey E Lancet, Jorge E Cortes, Donna E Hogge, et al.Environmental Pollution (Barking, Essex : 1987)|November 13, 2009
Inter-laboratory exercise on steroid estrogens in aqueous samplesE Heath, T Kosjek, H R Andersen, et al.Genes & Development|February 10, 2007
Defective N-sulfation of heparan sulfate proteoglycans limits PDGF-BB binding and pericyte recruitment in vascular developmentAlexandra Abramsson, Sindhulakshmi Kurup, Marta Busse, et al.Leukemia|December 17, 2005
Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trialsN Dhédin, H Dombret, X Thomas, et al.Genome Biology|July 17, 2025
Direct genetic transformation bypasses tumor-associated DNA methylation alterationsSara Hetzel, Eran Hodis, Elena Torlai Triglia, et al.Genome Research|June 7, 2015
High-throughput gene targeting and phenotyping in zebrafish using CRISPR/Cas9Gaurav K Varshney, Wuhong Pei, Matthew C LaFave, et al.Microbial Genomics|June 2, 2023
Pathogen genomics in public health laboratories: successes, challenges, and lessons learned from California's SARS-CoV-2 Whole-Genome Sequencing Initiative, California COVIDNetEmily A Smith, Kevin G Libuit, Curtis J Kapsak, et al.Annals of Hematology|April 30, 2022
A phase 1b study of glasdegib + azacitidine in patients with untreated acute myeloid leukemia and higher-risk myelodysplastic syndromesMikkael A Sekeres, Michael Schuster, Magalie Joris, et al.Pageof 47